The combination of FDA-cleared AI software for mammography triage with a medical grade edge AI platform may allow the embedding of enhanced AI detection capability within existing mammography devices.
Could an embedded AI system within mammography devices provide enhanced images, bolster workflow efficiency, and reduce hardware upgrade costs?
MedCognetics said the combination of its CogNet AI-MT AI-powered mammography software with the medical-grade edge AI platform NVIDIA IGX Orin enables real-time processing of high-quality mammography images.
MedCognetics said the combination of CogNet AI-MT AI-powered mammography software with the medical-grade edge AI platform NVIDIA IGX Orin facilitates improved image clarity and detail as well as worklist prioritization for a significantly lower cost than hardware upgrades for mammography devices. (Images courtesy of MedCognetics.)
The combination of AI technologies reportedly facilitates improved image clarity and detail as well as worklist prioritization for a significantly lower cost than hardware upgrades for mammography devices, according to MedCognetics.
“Embedding our CogNet AI-MT software directly into mammography imaging equipment means we can enhance image quality and provide immediate cancer detection without the need for costly hardware upgrades,” said Debasish “Ron” Nag, the CEO of MedCognetics. “Using the NVIDIA IGX platform, we’re advancing medical imaging technology, making high-quality diagnostic tools more accessible to radiologists and imaging centers around the world.”
Study Assesses Potential of Seven-Minute AI-Enhanced 3T MRI of the Shoulder
February 20th 2025Researchers found that the use of seven-minute threefold parallel imaging-accelerated deep learning 3T MRI had 89 percent sensitivity for supraspinatus-infraspinatus tendon tears and 93 percent sensitivity for superior labral tears.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.